Cargando…
An Observational Study of Hypertension and Thromboembolism Among Transgender Patients Using Gender-Affirming Hormone Therapy
Purpose: Given evidence from cisgender patients that sex hormones can impact risk for some forms of cardiovascular disease (CVD), there are concerns regarding CVD among transgender patients using gender-affirming hormone therapy (HT). Methods: Using a retrospective cohort at a U.S. urban federally q...
Autores principales: | Pyra, Maria, Casimiro, Isabel, Rusie, Laura, Ross, Nat, Blum, Cori, Keglovitz Baker, Kristin, Baker, Andie, Schneider, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc., publishers
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7173689/ https://www.ncbi.nlm.nih.gov/pubmed/32322683 http://dx.doi.org/10.1089/trgh.2019.0061 |
Ejemplares similares
-
Gender affirming hormone therapy dosing behaviors among transgender and nonbinary adults
por: Restar, Arjee, et al.
Publicado: (2022) -
Clinical pearls of gender-affirming hormone therapy in transgender patients
por: Irving, Amanda, et al.
Publicado: (2018) -
Gender-affirming Hormone Therapy and Risk of Diabetes in Transgender Persons
por: Tangpricha, Vin
Publicado: (2022) -
Cardiovascular Risk in Transgender People With Gender-Affirming Hormone Treatment
por: Masumori, Naoya, et al.
Publicado: (2023) -
Cardiovascular Risk Factors in Transgender People after Gender-Affirming Hormone Therapy
por: Sánchez-Toscano, Esteban, et al.
Publicado: (2023)